CN1022103C - 制备取代苯乙烯衍生物及其药用酸加成盐和其季铵盐的方法 - Google Patents

制备取代苯乙烯衍生物及其药用酸加成盐和其季铵盐的方法 Download PDF

Info

Publication number
CN1022103C
CN1022103C CN88105623A CN88105623A CN1022103C CN 1022103 C CN1022103 C CN 1022103C CN 88105623 A CN88105623 A CN 88105623A CN 88105623 A CN88105623 A CN 88105623A CN 1022103 C CN1022103 C CN 1022103C
Authority
CN
China
Prior art keywords
dimethyl
vinyl
mole
max
quaternary ammonium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN88105623A
Other languages
English (en)
Chinese (zh)
Other versions
CN1034709A (zh
Inventor
佐尔坦·巴德艾
卢赞·皮托切
蒂博·迈蔡
恩科·斯泽特
玛亚·森特艾
加布·吉格勒
克拉亚·赖特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Egis Gyógyszergyár Zrt
Original Assignee
Egis Gyógyszergyár Zrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Gyógyszergyár Zrt filed Critical Egis Gyógyszergyár Zrt
Publication of CN1034709A publication Critical patent/CN1034709A/zh
Application granted granted Critical
Publication of CN1022103C publication Critical patent/CN1022103C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32—Oximes
    • C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C251/44—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atom of at least one of the oxyimino groups being part of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
CN88105623A 1987-12-31 1988-12-29 制备取代苯乙烯衍生物及其药用酸加成盐和其季铵盐的方法 Expired - Fee Related CN1022103C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU6171/87 1987-12-31
HU876171A HU202195B (en) 1987-12-31 1987-12-31 Process for producing new substituted styrene derivatives and medical compositions comprising such compounds

Publications (2)

Publication Number Publication Date
CN1034709A CN1034709A (zh) 1989-08-16
CN1022103C true CN1022103C (zh) 1993-09-15

Family

ID=10971303

Family Applications (1)

Application Number Title Priority Date Filing Date
CN88105623A Expired - Fee Related CN1022103C (zh) 1987-12-31 1988-12-29 制备取代苯乙烯衍生物及其药用酸加成盐和其季铵盐的方法

Country Status (24)

Country Link
US (1) US4939142A (enExample)
JP (1) JPH0222258A (enExample)
CN (1) CN1022103C (enExample)
AT (1) AT396362B (enExample)
AU (1) AU610966B2 (enExample)
BE (1) BE1004906A3 (enExample)
CA (1) CA1326484C (enExample)
CH (1) CH678322A5 (enExample)
CS (1) CS274494B2 (enExample)
DD (1) DD287491A5 (enExample)
DE (1) DE3900028A1 (enExample)
DK (1) DK728888A (enExample)
ES (1) ES2024077A6 (enExample)
FI (1) FI90867C (enExample)
FR (1) FR2625501B1 (enExample)
GB (1) GB2213481B (enExample)
GR (1) GR1002384B (enExample)
HU (1) HU202195B (enExample)
IL (1) IL88827A (enExample)
IT (1) IT1227919B (enExample)
NL (1) NL8803221A (enExample)
PL (1) PL154358B1 (enExample)
SE (1) SE503227C2 (enExample)
YU (1) YU47605B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT67314A (en) * 1993-04-09 1995-03-28 Egyt Gyogyszervegyeszeti Gyar Process for prepg. new trisubstituted cykloalkane deriv.s and pharmaceutical compn.s contg. them
US6573282B1 (en) 1995-09-12 2003-06-03 Adolor Corporation Peripherally active anti-hyperalgesic opiates
US5849761A (en) 1995-09-12 1998-12-15 Regents Of The University Of California Peripherally active anti-hyperalgesic opiates
WO2001068621A1 (en) * 2000-03-13 2001-09-20 Ortho-Mcneil Pharmaceutical, Inc. Novel cyclohexene derivatives useful as antagonists of the motilin receptor
US7415634B2 (en) * 2004-03-25 2008-08-19 International Business Machines Corporation Method for fast system recovery via degraded reboot
JP4912281B2 (ja) * 2007-11-27 2012-04-11 三菱電機株式会社 回路基板のはんだ付け用治具
US20100021276A1 (en) * 2008-07-24 2010-01-28 James Baughman Tilt loading platform for wheeled vehicles
CA2981080A1 (en) * 2015-04-15 2016-10-20 Valent Biosciences Llc (s)-2'-vinyl-abscisic acid derivatives
WO2019084476A1 (en) * 2017-10-26 2019-05-02 University Of Tennessee Research Foundation ANTAGONISTS OF FIBROBLAST GROWTH FACTOR 23 AND RELATED COMPOSITIONS AND METHODS
CN110305054B (zh) * 2019-07-19 2021-03-02 哈尔滨工业大学 一种双取代苯乙烯类衍生物的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1493222A (en) * 1976-01-27 1977-11-30 Egyt Gyogyszervegyeszeti Gyar Cycloalkanone oxime ethers and process for the preparation thereof
US4083978A (en) * 1976-01-27 1978-04-11 Egyt Gyogyszervegyeszeti Gyar Oxime ethers
HU180739B (en) * 1979-07-03 1983-04-29 Egyt Gyogyszervegyeszeti Gyar Process for producing basic oxime-ethers
HU189227B (en) * 1983-02-08 1986-06-30 Egyt Gyogyszervegyeszeti Gyar,Hu Process for preparing basic oxime-ethers
HU189226B (en) * 1983-02-08 1986-06-30 Egyt Gyogyszervegyeszeti Gyar,Hu Process for producing basic oxime-ethers
HU188250B (en) * 1983-02-08 1986-03-28 Egyt Gyogyszervegyeszeti Gyar,Hu Process for producing of basical oxim-ethers
HU197205B (en) * 1984-07-10 1989-03-28 Egyt Gyogyszervegyeszeti Gyar Process for production of medical compositions against angine
US4803286A (en) * 1987-08-19 1989-02-07 Merck & Co., Inc. Amino-2-hydroxypropyloximinoheterocycle α-blockers

Also Published As

Publication number Publication date
IL88827A (en) 1993-01-14
GB2213481A (en) 1989-08-16
IL88827A0 (en) 1989-07-31
CS900788A2 (en) 1990-09-12
AT396362B (de) 1993-08-25
DD287491A5 (de) 1991-02-28
CS274494B2 (en) 1991-04-11
JPH0222258A (ja) 1990-01-25
PL154358B1 (en) 1991-08-30
HUT48867A (en) 1989-07-28
YU47605B (sh) 1995-10-24
CN1034709A (zh) 1989-08-16
GR880100869A (el) 1994-03-31
DE3900028A1 (de) 1989-07-13
PL276892A1 (en) 1989-08-21
FI90867B (fi) 1993-12-31
SE8804688L (sv) 1989-07-01
SE8804688D0 (sv) 1988-12-29
DK728888D0 (da) 1988-12-29
AU2762788A (en) 1989-07-06
FI90867C (fi) 1994-04-11
AU610966B2 (en) 1991-05-30
GB2213481B (en) 1991-07-17
GB8830417D0 (en) 1989-03-01
HU202195B (en) 1991-02-28
IT8823180A0 (it) 1988-12-30
CA1326484C (en) 1994-01-25
NL8803221A (nl) 1989-07-17
YU238288A (en) 1990-06-30
CH678322A5 (enExample) 1991-08-30
FI886066A7 (fi) 1989-07-01
US4939142A (en) 1990-07-03
IT1227919B (it) 1991-05-14
FR2625501B1 (fr) 1993-05-21
ATA320788A (de) 1992-12-15
DK728888A (da) 1989-07-01
ES2024077A6 (es) 1992-02-16
BE1004906A3 (fr) 1993-02-23
GR1002384B (el) 1996-07-03
FR2625501A1 (fr) 1989-07-07
SE503227C2 (sv) 1996-04-22

Similar Documents

Publication Publication Date Title
CN1110495C (zh) 芳烷基二嗪酮，其制备方法及其药物制剂
CN1024547C (zh) 一类环胺化合物的制备方法
CN1020093C (zh) 1-苯基-3-萘氧基丙胺的制备方法
CN1699343A (zh) 盐酸多奈哌齐的多晶型物及其制备方法
CN101050194A (zh) 双环辛烷类衍生物、其制备方法及其在医药上的用途
CN1220602A (zh) 抗病毒化合物
CN1154483C (zh) 胺化合物用于制备阻止肿瘤细胞增殖的药物
CN1080917A (zh) 联苯衍生物，含这些化合物的药物组合物及其制备方法
CN1946406A (zh) 治疗呼吸道疾病的苯并噁嗪
CN1030450C (zh) 镇痛羧酸酰胺衍生物的制备方法
CN87100978A (zh) 新的二氢苯并呋喃—和苯并二氢吡喃—羧酰胺衍生物及其制备方法以及作为精神抑制药的应用
CN1094039A (zh) 芳酰胺衍生物
CN1064273A (zh) 新的具有ngf生成促进活性的苯衍生物
CN1216052C (zh) 抗神经变性活性的10－氨基脂族基二苯并[b,f]噁庚英
CN1034709A (zh) 取代的苯乙烯衍生物
CN1254334A (zh) 新颖的对苯二甲酰胺衍生物
CN1668584A (zh) 作为抗分支杆菌化合物的吡咯衍生物
CN1284777C (zh) 5元杂环化合物、它们的制备和作为药物的应用
CN1043706A (zh) 4，5，6，7-四氢化苯并咪唑衍生物制备方法
CN1397557A (zh) 新的八氢－2H－吡啶并[1,2－a]吡嗪化合物、它们的制备方法和含有它们的药物组合物
CN1207282C (zh) 盐酸多奈哌齐的多晶型物（iii），其制备方法及用途
CN1721417A (zh) 新的吡咯烷和噻唑烷化合物、它们的制备方法和包含它们的药物组合物
CN100338037C (zh) 新的苯甲酰基哌啶化合物
CN1859949A (zh) 4a,5,9,10,11,12－六氢苯并呋喃[3a,3,2][2]－苯并氮杂䓬的新衍生物,其制备方法及其在药剂制备中的应用
CN1622945A (zh) 噻唑烷二酮衍生物以及包含该衍生物的药物组合物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee